TB-CAPT progress meeting and data unblinding

From 02-04 October the TB-CAPT Consortium convened for a face-to-face progress meeting in Dar-es-Salaam, Tanzania, hosted by local project partners from Ifakara Health Institute. The first day of the meeting started with a presentation on the primary analysis for the TB-CAPT XDR study, which evaluates diagnostic accuracy and feasibility of the Xpert MTB/XDR cartridge in comparison to the current standards of care. This was followed by a status overview of the ongoing EXULTANT trial which investigates the added value of expanded diagnostic testing for hospitalised people living with HIV. EXULTANT recruitment is ongoing, aiming for completion in the next months.

The second day saw the data unblinding session for the TB-CAPT CORE trial, which looked at how modern TB diagnostics can be applied in primary healthcare clinics, and their potential impact on patient care. The results were very exciting and will be presented at the upcoming Eleventh EDCTP Forum.

The last meeting day began with a site visit to clinics that contributed to the TB-CAPT CORE study. All visitors appreciated the opportunity to see in person how the day-to-day work of their colleagues is carried out. Smaller work sessions in the afternoon concluded the meeting.

In summary, the TB-CAPT consortium meeting was a very successful event. It provided an opportunity for partners to come together, discuss progress, and share lessons learned. The results of the CORE trial are particularly exciting, and the consortium looks forward to sharing them with the wider TB community at the EDCTP Forum. The TB-CAPT Scientific symposium is scheduled for Thursday 9 November 16:30-18:00.